HIV infections Trials in Wichita, United States
Conditions / HIV infections / Wichita, United States
HIV infections has been the subject of sustained clinical investigation across multiple research sites.
47 total trials for this combination
Showing top 10 of 47 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00027352 | A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study) | COMPLETED | — |
| NCT00002124 | A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3 | COMPLETED | PHASE3 |
| NCT04542070 | A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed | COMPLETED | PHASE3 |
| NCT00004583 | A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy | COMPLETED | PHASE3 |
| NCT00004581 | A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment | COMPLETED | PHASE3 |
| NCT00000672 | An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex | COMPLETED | PHASE2 |
| NCT00002123 | A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3 | COMPLETED | PHASE3 |
| NCT00013897 | A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine | COMPLETED | PHASE3 |
| NCT00146328 | Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects | COMPLETED | PHASE2/PHASE3 |
| NCT00426660 | Expanded Access Program for Maraviroc At Multiple Centers | COMPLETED | PHASE3 |